DE

Germany

28125 clinical trials

Find Trials

Clinical Trials (28125)

Showing 20 of 28,125 trialsScroll for more
NCT06291376Phase 312 sites

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting

Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
NCT06859099Phase 32 sites

Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP

Enrolling By Invitation
NCT05450692Phase 37 sites

A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

Active Not Recruiting
NCT04973605Phase 14 sites

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

Recruiting
NCT06632444Phase 317 sites

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Recruiting
NCT06073821Phase 33 sites

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

Active Not Recruiting
NCT05587296Phase 312 sites

A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer

Active Not Recruiting
NCT06862453Phase 11 site

Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults

Recruiting
NCT06846671Phase 312 sites

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

Recruiting
NCT05296798Phase 313 sites

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Active Not Recruiting
NCT04421963Phase 31 site

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Active Not Recruiting
NCT06684847Phase 34 sites

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome

Active Not Recruiting
NCT06456346Phase 38 sites

Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)

Recruiting
NCT07175038Phase 21 site

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

Recruiting
NCT06152575Phase 312 sites

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Recruiting
NCT05001269Phase 22 sites

Nedosiran in Pediatric Patients From Birth to 11 Years of Age With PH and Relatively Intact Renal Function

Completed

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

Recruiting
NCT06629779Phase 34 sites

A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Recruiting